Advertisement

Pharmaceutisch Weekblad

, Volume 4, Issue 2, pp 25–31 | Cite as

Hexamethylmelamine and hexamethylmelamine hydrochloride

  • H. P. C. Van De Vaart-Van Zutphen
  • C. F. A. Smulders
  • J. Renema
  • A. Hulshoff
Review Articles

Abstract

Methods of analysis of the anticancer drug hexamethylmelamine, its physicochemical properties, its therapeutic uses and its fatein vivo upon oral administration, are described. The data are taken in part from the literature, in part from our own studies.

The low solubility of hexamethylmelamine in water has prevented the parenteral administration of the drug to humans. The preparation of the water-soluble monohydrochloride of hexamethylmelamine, which may be suitable for this purpose, is reported, as well as its physicochemical characteristics and methods of analysis.

Keywords

Public Health Internal Medicine Hydrochloride Oral Administration Physicochemical Property 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ames, M.M., G. Powis, J.S. Kovach andR.T. Eagan (1979)Cancer Res. 39, 5016–5021.PubMedGoogle Scholar
  2. Bellamy, L.J. (1975)The Infra-red Spectra of Complex Molecules, 3rd ed. Chapman & Hall, London, 17, 316.Google Scholar
  3. Bryan, G.T., andA.L. Gorske (1968)J. Chromatog. 34, 67–71.CrossRefGoogle Scholar
  4. Chang, S.C., A.B. Demilo, C.W. Woods andA.B. Borkovec (1968)J. Econ. Entomol. 61, 1357–1365.PubMedGoogle Scholar
  5. Cincotta, J.J., andR. Feinland (1962)Anal. Chem. 34, 774–776.CrossRefGoogle Scholar
  6. Cumber, A.J., andW.C.J. Ross (1977)Chem.-Biol. Interactions 17, 349–357.CrossRefGoogle Scholar
  7. Feigl, F., andV. Anger (1975)Spot tests in organic analysis, translated by R.E.Oesper. English Ed. VII. Elsevier Scientific Publ. Comp., Amsterdam-Oxford-New York, 251–252.Google Scholar
  8. Gescher, A., M. D'Incalci, R. Fanelli andP. Farina (1980)Life Sci. 26, 147–154.CrossRefPubMedGoogle Scholar
  9. Hulshoff, A., J.P. Neijt, C.F.A. Smulders, A.C. Van Loenen andH.M. Pinedo (1980a)J. Chromatog. 181, 363–371.Google Scholar
  10. Hulshoff, A., J.P. Neijt, C.F.A. Smulders andA.C. Van Loenen (1980b)Proc. Am. Assoc. Cancer Res. 21, 301.Google Scholar
  11. D'incalci, M., G. Bolis, C. Mangioni, L. Morasca andS. Garattini (1978)Cancer Treat. Rep. 62, 2117–2119.PubMedGoogle Scholar
  12. D'incalci, M., P. Morazzoni andC. Pantarotto (1979)Anal. Biochem. 99, 441–449.CrossRefPubMedGoogle Scholar
  13. D'incalci, M., P. Farina, C. Sessa, E. Erba, R. Madonna andC. Mangioni (1980)Therap. Drug Monitoring 2, 187–188.Google Scholar
  14. Johnson, B.L., R.I. Fisher, R.A. Bender, V.T. De Vita, B.A. Chabner andR.C. Young (1978)Cancer 42, 2157–2161.PubMedGoogle Scholar
  15. Kaiser, D.W., J.T. Thurston, J.R. Dudley, F.C. Schaefer, I. Hechenbleikner andD. Holm-Hansen (1951)J. Am. Chem. Soc. 73, 2984–2986.CrossRefGoogle Scholar
  16. Kreilgard, B., T. Higuchi andA.J. Repta (1975)J. Pharm. Sci. 64, 1850–1855.PubMedGoogle Scholar
  17. Legha, S.S., M. Slavik andS.K. Carter (1976)Cancer 38, 27–35.PubMedGoogle Scholar
  18. Morimoto, M., D. Green, A. Rahman, A. Goldin andP.S. Schein (1980)Cancer Res. 40, 2762–2767.PubMedGoogle Scholar
  19. Neijt, J.P., A.C.M. Van Lindert, C.P.J. Vendrik, K.J. Roozendaal, A. Struyvenberg andH.M. Pinedo (1979)Neth. J. Med. 22, 38–44.PubMedGoogle Scholar
  20. Pohloudek-Fabini, R., andTh. Beyrich (1975)Organische Analyse. Akademische Verlagsgesellschaft Geest & Porting K-G, Leipzig, 338.Google Scholar
  21. Rutty, C.J., andT.A. Connors (1977)Biochem. Pharmacol. 26, 2385–2391.CrossRefPubMedGoogle Scholar
  22. Wehrli, F.W., and T.Wirthlin (1976)Interpretation of Carbon-13 NMR Spectra. Heyden, London-New York-Rheine.Google Scholar
  23. Williams, D.H., andI. Fleming (1966)Spectroscopic Methods in Organic Chemistry. McGraw-Hill, London, 126.Google Scholar
  24. Worzalla, J.F., B.M. Johnson, G. Ramirez andG.T. Bryan (1973)Cancer Res. 33, 2810–2815.PubMedGoogle Scholar
  25. Young, R.C., B.A. Chabner, S.P. Hubbard, R.I. Fisher, R.A. Bender, T. Anderson, R.M. Simon, G.P. Canellos andV.T. De Vita (1978)New Engl. J. Med. 299, 1261–1266.PubMedGoogle Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1982

Authors and Affiliations

  • H. P. C. Van De Vaart-Van Zutphen
    • 1
  • C. F. A. Smulders
    • 1
  • J. Renema
    • 1
  • A. Hulshoff
    • 1
  1. 1.Pharmaceutical Laboratory, Department of Analytical PharmacyUniversity of UtrechtGH UtrechtThe Netherlands

Personalised recommendations